Epilepsy Therapeutics Market Research 2024: A $15.8+ Billion Market by 2030 - Focus on United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India Dublin, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The "Epilepsy Therapeutics Market (2024 Edition): Analysis by Generation (First Generation, Second Generation, Third Generation), Route of Administration,...

Global Friedreich's Ataxia Market Analysis 2023-2034: A Projected $3.39 Billion Opportunity Featuring Strategic Analysis of Reata Pharma, Pfizer, BioMarin Pharma, Retrotope, Voyager Therapeutics, and More Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Global Friedreich's Ataxia Market" report has been added to ResearchAndMarkets.com's offering.The global Friedreich's ataxia market accounted for USD...

Second Generation Anti-Epileptic Drugs (AEDs) Dominate the Market in 2022, While Third Generation AEDs Projected to Exhibit the Fastest Growth Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Anti-Epileptic Drugs Market: Analysis By Drug Generation, By Distribution Channel, By Region Size and Trends with Impact of COVID-19 and...

Outlook on the Central Nervous System Drugs Global Market to 2030 - Identify Growth Segments for Investment Dublin, May 10, 2021 (GLOBE NEWSWIRE) -- The "Central Nervous System Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's...